Malaria
OneWorld Health, Amyris Biotechnologies and sanofi-aventis Announce Development Agreement for Semisynthetic Artemisinin
Published in Lab Law Weekly, March 21st, 2008
The Institute for OneWorld Health (iOWH), the U.S.-based nonprofit pharmaceutical company, together with synthetic biology innovator Amyris Biotechnologies, and leading pharmaceutical company sanofi-aventis, announced they have entered into an agreement for the development of semisynthetic artemisinin, a key ingredient in first-line malaria treatments. This partnership will build on technology originated by Professor Jay Keasling at the University of California, Berkeley.
This collaboration aims to create a complementary source of non-seasonal, high-quality and affordable artemisinin to supplement the current botanical supply, thereby enabling millions of people...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Law Weekly
Source: Lab Law Weekly (2008-03-21)
More Articles from Lab Law Weekly
- AARP
Utilities, Long Term Care Bills at Center of 'AARP Day In Annapolis' - Adams Management Services Corporation
ADAMS Welcomes Debbie Aiken and Brandon Cannaday to the Firm's Staff as Associate Project Managers - Allergies
Biovator Attracts New Investment Partner - Allstate Insurance Company
Alleged Multi-Million Dollar Fraud Ring Target of Federal Lawsuit - Amarin Corporation Plc
Amarin Secures Global Intellectual Property Rights for Lipid Programs - American Association of Colleges of Nursing
AACN Applauds Senator Richard Durbin for Introducing the Troops to Nurse Teachers Act of 2008 - More from this issue of Lab Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
